Triple negative status is a poor prognostic indicator in Chinese women with breast cancer: A ten year review

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 5, 2012, Pages 2109-2114

  Ma, K K ^a   Chau, Wai Wang ^a   Wong, Connie HN ^a   Wong, Kerry ^a   Fung, Nicholas ^a   Lee, Andrea J T ^a   Choi, Catherine L Y ^a   Suen, Dacita T K ^a   Kwong, Ava ^a,b  

^a TUNG WAH HOSPITAL   (Hong Kong)

^b Hong Kong Hereditary Breast Cancer Family Registry   (China)

Author keywords

Asian continental ancestry group; Breast neoplasms; Epidemiology; Mortality; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; ASIAN; BREAST TUMOR; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL RATE; TERTIARY HEALTH CARE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TERTIARY CARE CENTERS;

EID: 84872687525     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.5.2109     Document Type: Article

References (30)

1. American Joint Committee on Cancer. http://www.cancerstaging.org.
2. Banerjee S, Reis-Filho JS, Ashley S, et al (2006). Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clinical Pathology, 59, 729-35.
3. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007). Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer, 109, 1721-8.
4. Bloom HJ, Richardson WW (1957). Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer, 11, 359-77.
5. Carey LA, Perou CM, Livasy CA, et al (2006). Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, 295, 2492-502.
6. Cheang MC, Voduc D, Bajdik C, et al (2008). Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res, 14, 1368-76.
7. Dent R, Hanna WM, Trudeau M, et al (2009). Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res Treat, 115, 423-8.
8. Elias AD (2010). Triple-negative breast cancer: a short review. Am J Clinical Oncol, 33, 637-45.
9. Fleming ID (2001). AJCC/TNM cancer staging, present and future. J Surg Oncol, 77, 233-6.
10. Gluz O, Liedtke C, Gottschalk N, et al (2009). Triple-negative breast cancer-current status and future directions. Ann Oncol, 20, 1913-27.
11. Haffty BG, Yang Q, Reiss M, et al (2006). Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol, 24, 5652-7
12. Kurebayashi J, Moriya T, Ishida T, et al (2007) The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races Breast, 16, 72-7.
13. Kusinska R, Potemski P, Jesionek-Kupnicka D, Kordek R (2005). Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma-relation with grade, stage, estrogen receptor and HER2. Polish J Pathol, 56, 107-10.
14. Kwan ML, Kushi LH, Weltzien E, et al (2009). Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res, 11, 31.
15. Lara-Medina F, Perez-Sanchez V, Saavedra-Perez D, et al (2011). Triple-negative breast cancer in hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer, 117, 3658-69.
16. Lee JA, Kim KI, Bae JW, et al (2010). Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival. Breast Cancer Res Treat, 123, 177-87.
17. Lin C, Chien SY, Chen LS, et al (2009a). Triple negative breast carcinoma is a prognostic factor in Taiwanese women. BMC Cancer, 9, 192.
18. Lin Y, Yin W, Yan T, et al (2009b). Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients. BMC Cancer, 9, 342.
19. Lund MJ, Trivers KF, Porter PL, et al (2009). Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Research & Treatment, 113, 357-70.
20. Millikan RC, Newman B, Tse CK, et al (2008). Epidemiology of basal-like breast cancer. Breast Cancer Res Treat, 109, 123-39.
21. O'Shaughnessy J, Osborne C, Pippen JE, et al (2011). Iniparib plus chemotherapy in metastatic triple-negative breast cancer. New England J Med, 364, 205-14.
22. Plummer R (2011). Poly (ADP-ribose) polymerase inhibition: a new direction for BRCA and triple-negative breast cancer. Breast Cancer Research, 13, 218.
23. Rakha EA, El-Sayed ME, Green AR, et al (2007). Prognostic markers in triple-negative breast cancer. Cancer, 109, 25-32.
24. Rodriguez-Pinilla SM, Sarrio D, Honrado E, et al (2006). Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res, 12, 1533-9.
25. Saip P, Cicin I, Eralp Y, et al (2009). Identification of patients who may benefit from the prophylactic cranial radiotherapy among breast cancer patients with brain metastasis. J Neurooncol, 93, 243-51.
26. Tan DS, Marchio C, Jones RL, et al (2008). Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Treat, 111, 27-44.
27. Thike AA, Iqbal J, Cheok PY, et al (2010). Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers. Am J Surgical Pathol, 34, 956-64.
28. Tischkowitz M, Brunet JS, Begin LR, et al (2007). Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. BMC Cancer, 7, 134.
29. Yao-lung K, Dar-ren C, Tsai-wang C (2011). Clinicopathological features of triple-negative breast cancer in Taiwanese women. Int J Clinical Oncol, 16, 500-5.
30. Yin WJ, Lu JS, Di GH, et al (2009). Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients. Breast Cancer Res Treat, 115, 325-33.